OBJECTIVE: To determine the relationship between serum vitamin D levels and cardiometabolic risk factors independent of adiposity in urban schoolchildren. STUDY DESIGN: We assessed the relationships among serum 25-hydroxyvitamin D [25(OH)D], adiposity measured by body mass index (BMI) z-score (BMIz), and 6 cardiometabolic risk factors (total cholesterol, high-density lipoprotein cholesterol, low-density lipoprotein cholesterol, triglycerides, interleukin-6, and C-reactive protein [CRP]) in a cross-sectional sample of 263 racially and ethnically diverse schoolchildren from the Boston area during late winter. Multivariate regression analyses adjusting for sociodemographic characteristics and BMIz examined associations of 25(OH)D and cardiometabolic risk factors. RESULTS: Overall, 74.6% of the children were vitamin D deficient [25(OH)D <50 nmol/L; mean, 41.8 ± 13.7 nmol/L]; 45% were overweight or obese (20% and 25%, respectively; BMIz = 0.75 ± 1.1). The 25(OH)D level was not associated with BMIz, but was positively associated with the cardiometabolic risk factor CRP (β = 0.03; P < .05). BMIz was associated with elevated triglycerides (β = 0.13), CRP (β = 0.58), and interleukin-6 (β= 0.14) and low high-density lipoprotein cholesterol (β = -0.09; all P < .01). CONCLUSIONS: Vitamin D deficiency is highly prevalent during the late winter months in urban schoolchildren living in the northeastern United States. This widespread deficiency may contribute to the lack of associations between 25(OH)D and both BMIz and cardiometabolic risk factors. The association between 25(OH)D and CRP warrants further study.
OBJECTIVE: To determine the relationship between serum vitamin D levels and cardiometabolic risk factors independent of adiposity in urban schoolchildren. STUDY DESIGN: We assessed the relationships among serum 25-hydroxyvitamin D [25(OH)D], adiposity measured by body mass index (BMI) z-score (BMIz), and 6 cardiometabolic risk factors (total cholesterol, high-density lipoprotein cholesterol, low-density lipoprotein cholesterol, triglycerides, interleukin-6, and C-reactive protein [CRP]) in a cross-sectional sample of 263 racially and ethnically diverse schoolchildren from the Boston area during late winter. Multivariate regression analyses adjusting for sociodemographic characteristics and BMIz examined associations of 25(OH)D and cardiometabolic risk factors. RESULTS: Overall, 74.6% of the children were vitamin D deficient [25(OH)D <50 nmol/L; mean, 41.8 ± 13.7 nmol/L]; 45% were overweight or obese (20% and 25%, respectively; BMIz = 0.75 ± 1.1). The 25(OH)D level was not associated with BMIz, but was positively associated with the cardiometabolic risk factor CRP (β = 0.03; P < .05). BMIz was associated with elevated triglycerides (β = 0.13), CRP (β = 0.58), and interleukin-6 (β= 0.14) and low high-density lipoprotein cholesterol (β = -0.09; all P < .01). CONCLUSIONS:Vitamin D deficiency is highly prevalent during the late winter months in urban schoolchildren living in the northeastern United States. This widespread deficiency may contribute to the lack of associations between 25(OH)D and both BMIz and cardiometabolic risk factors. The association between 25(OH)D and CRP warrants further study.
Authors: Catherine M Gordon; Henry A Feldman; Linda Sinclair; Avery LeBoff Williams; Paul K Kleinman; Jeannette Perez-Rossello; Joanne E Cox Journal: Arch Pediatr Adolesc Med Date: 2008-06
Authors: Lauren E Au; Susan S Harris; Paul F Jacques; Johanna T Dwyer; Jennifer M Sacheck Journal: J Acad Nutr Diet Date: 2013-08-30 Impact factor: 4.910
Authors: Jennifer M Sacheck; Maria I Van Rompay; Elizabeth M Olson; Virginia R Chomitz; Elizabeth Goodman; Catherine M Gordon; Misha Eliasziw; Michael F Holick; Christina D Economos Journal: Clin Trials Date: 2014-10-27 Impact factor: 2.486
Authors: Caleigh M Sawicki; Maria I Van Rompay; Lauren E Au; Catherine M Gordon; Jennifer M Sacheck Journal: J Nutr Date: 2016-03-02 Impact factor: 4.798
Authors: Lauren E Au; Susan S Harris; Johanna T Dwyer; Paul F Jacques; Jennifer M Sacheck Journal: J Pediatr Endocrinol Metab Date: 2014-11 Impact factor: 1.634
Authors: Jennifer M Sacheck; Maria I Van Rompay; Virginia R Chomitz; Christina D Economos; Misha Eliasziw; Elizabeth Goodman; Catherine M Gordon; Michael F Holick Journal: J Clin Endocrinol Metab Date: 2017-12-01 Impact factor: 5.958
Authors: Lauren E Au; Christina D Economos; Elizabeth Goodman; Aviva Must; Virginia R Chomitz; Jennifer M Sacheck Journal: Public Health Nutr Date: 2012-08-03 Impact factor: 4.022